Post-market surveillance is required to

Prepare for the Drug Discovery and Healthcare Systems Test. Access flashcards and multiple-choice questions with hints and explanations. Ace your exam with our comprehensive resources!

Multiple Choice

Post-market surveillance is required to

Post-market surveillance is the ongoing safety monitoring of a drug after it reaches patients. Its main purpose is to uncover rare or long-term adverse effects that may not appear in premarket trials because those studies involve a finite number of participants and limited follow-up time. By gathering real-world reports and analyzing safety signals, regulators and manufacturers can reassess the risk–benefit balance and take actions such as updating labels, adding warnings, restricting use, or even withdrawing a product if necessary. This focus on detecting rare adverse effects is why post-market surveillance is required. It isn’t primarily about speeding up approvals, increasing market share, or improving manufacturing efficiency, which come from other aspects of development and regulatory work.

Post-market surveillance is the ongoing safety monitoring of a drug after it reaches patients. Its main purpose is to uncover rare or long-term adverse effects that may not appear in premarket trials because those studies involve a finite number of participants and limited follow-up time. By gathering real-world reports and analyzing safety signals, regulators and manufacturers can reassess the risk–benefit balance and take actions such as updating labels, adding warnings, restricting use, or even withdrawing a product if necessary. This focus on detecting rare adverse effects is why post-market surveillance is required. It isn’t primarily about speeding up approvals, increasing market share, or improving manufacturing efficiency, which come from other aspects of development and regulatory work.

More practice questions